References
- Shoenfeld Y, Ben-Tal O, Berliner S, Pinkhas J (1985) The outcome of bacterial infection in subjects with benign familial leukopenia (BFL). Biomed Pharmacother 39: 23–6.
- Berrebi A, Melamed Y, Van Dam U (1987) Leukopenia in Ethiopian Jews. New Engl J Med 316: 549.
- Shoenfeld Y, Alkan ML, Asaly A et al (1988) Benign familial leukopenia and neutropenia in different ethnic groups. Eur J Haematol 41: 273–7.
- Huber H (1939) Schtambammunterchungen bel panmyelophtisenkranken. Klin Wocheschr 18: 1145.
- Davis LR (1967) Leukopenia in West Indians and Africans. Lancet 2: 213.
- Ezeilo GC (1971) Neutropenia in Africans. Trop Geogr Med 23: 264–7.
- Sharper AG, Lewis P (1971) Genetic neutropenia in people of African origin. Lancet ii: 1021—3.
- Ezeilo GC (1974) The aetiology of neutropenia in healthy Africans. East Afr MedJ 51: 936–42.
- Rougemont A, Boisson ME (1975) Racial differences in leukocyte count. Br MedJ 2: 684–5.
- Alvir JM, Lieberman JA, Safferman AZ et al (1993) Clozapine-induced agranulocytosis: incidence and risk factors in the United States. N EngJ Med 329: 162–7.
- Lieberman JA, Yunis J, Egea E, Canoso RT (1990) HLA-B38, DR4, DQw3 and clozapine-induced agranulocytosis in Jewish patients with schizophrenia. Arch Gen Psychiatry 47: 945–8.
- Yunis JJ, Corzo D, Salazar M et al (1995) HLA associations in clozapine-induced agranulocytosis. Blood 86: 1177—83.
- Valevski A, Klein T, Gazit E et al (1998) HLA-B38 and clozapine-induced agranulocytosis in Israeli Jewish schizophrenic patients. EurJ Immunogenet 25: 11–3.
- Meged S, Stein D, Sirota P et al (1999) Human leukocyte antigen typing, response to neuroleptics, and clozapine-induced agranulocytosis in Jewish Israeli schizophrenic patients. Int Clin Psychopharmacol 14: 305–12.
- Reznik I, Mester R (2000) Genetic factors in clozapine-induced agranulocytosis. Isr Med Assoc J 2: 857–8.
- Buchman N, Strous RD, Ulman AM et al (2001) Olanzapine-induced leukopenia with human leukocyte antigen profiling. Int Clin Psychopharmacol 16: 55–7.
- King DJ, Wager E (1998) Haematological safety of antipsychotic drugs. J Psychopharmacol 12:283–8.
- Malhotra AK, Litman RE, Pickar D (1993) Adverse effects of antipsychotic drugs. Drug Saf 9: 429—36.
- Grohmann R, Schmidt LG, Spiess-Kiefer C, Ruther E (1989) Agranulocytosis and significant leucopenia with neuroleptic drugs: results from the AMUP program. Psychopharmacology (Berlin) (Suppl) 99: S109–12.
- Hong X, Wang X (2001) Agranulocytosis and neutropenia with typical and atypical neuroleptics. AmJ Psychiatry 158: 1736—7.
- Danielson DA, Douglas SW, Herzog P et al (1984) Drug-induced blood disorders. J Am Med Assoc 252: 3257–60.
- Dettling M, Cascorbi I, Hellweg R et al (1999) Genetic determinants of drug induced agranulocytosis: potential risk of olanzapine? Pharmacopsychiatry 32: 110–2.
- Pisciotta AV, Konings SA, Ciesemier LL et al (1992) On the possible mechanisms and predictability of clozapine-induced agranulocytosis. Drug Saf 7 (Suppl 1): 33—44.
- Pfister GM, Hanson DR, Roerig JL et al (1992) Clozapine-induced agranulocytosis in a Native American: HLA typing and further support for an immune-mediated mechanism. J Clin Psychiatry 53: 242–4.
- Corzo D, Yunis JJ, Yunis EJ et al (1994) HSP70-2 9.0 kb variant is in linkage disequilibrium with the HLA-B and DRB1* alleles associated with clozapine-induced agranulocytosis. J Clin Psychiatry (Suppl B) 55: 149–52.
- Corzo D, Yunis JJ, Salazar M et al (1995) The major histocompatibility coregion marked by HSP70-1 and HSP70-2 variants is associated with clozapine-induced agranulocytosis in two different ethnic groups. Blood 86: 3835—40.
- Hirshberg B, Gural A, Caraco Y (2000) Zuclopenthixol-associated neutropenia and thrombocytopenia. Ann Pharmacother 34: 740 — 1.
- Biswas A, Mittal P, Chaturvedi S, Prasad A (2000) Risperidone induced cytopenias. J Assoc Phys India 48: 1122–3.
- Dernovsek MZ, Tavcar R (2000) Olanzapine appears haematologically safe in patients who developed blood dyscrasia on clozapine and risperidone. Int Clin Psychopharmacol 15: 237 — 8.
- Finkel B, Lerner AG, Oyffe I, Sigal M (1998) Risperidone-associated agranulocytosis. AmJ Psychiatry 155: 855—6.
- Dernovsek Z, Tavcar R (1997) Risperidone-induced leucopenia and neutropenia. Br J Psychiatry 171: 393—4.
- Bondolfi G, Morena P, Dascal DR, Bertschy G (1996) Risperidone and reversible neutropenia: a negative rechallenge. Eur Neuropsychopharmacol 6: 257.